Home About Products & Services News Research Investors Contact


Judy P. Ways, Ph.D., VP Regulatory Affairs and Quality Assurance

Dr. Ways has more than 20 years of experience in pharmaceutical development, regulatory affairs and quality assurance spanning medical devices, drugs and biologics. Dr. Ways was previously VP, RA/QA Neuron Therapeutics. Prior to Neuron she was VP of Regulatory Affairs at MedImmune, Inc. Prior to MedImmune, Dr. Ways held senior level regulatory and quality positions with Aventis Behring Ltd. and Glaxo Research Institute where she interacted extensively with the FDA and other worldwide regulatory agencies on regulatory submissions and compliance activities.

Back

Find a NeuroStar TMS Therapy Provider Near You

If you or a loved one is suffering from major depression, you can find a NeuroStar TMS Therapy provider in your area.

Provide NeuroStar TMS Therapy in Your Practice

Provide your patients the new way back with NeuroStar TMS Therapy®. Contact us to find out how you can begin providing therapy.

This link provides you with access to recent published information and news about NeuroStar TMS Therapy and new options for the treatment of depression. Neuronetics does not provide any assurances of the accuracy of this information and may not agree with the opinions of the authors.

NeuroStar TMS Therapy is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode. To return to the Neuronetics website for full safety and prescribing information click here.

Click here to continue.